Condition: Dengue · Antiviral Drugs · Sponsor: Oxford University Clinical Research Unit, Vietnam
This is a randomized, open-label adaptive platform trial aiming to screen the antiviral effectiveness of the experimental drug(s) in early dengue infection * Primary objectives: * To determine the antiviral effectiveness of the experimental drug(s) in early dengue infection * To assess the safety and tolerability of the experimental drug(s) in dengue patients * Secondary objective: * To assess the effect of the experimental drug(s) in dengue patients on physiological, clinical and virological parameters
This description comes directly from the study's public registry record.
Sophie Yacoub, MD., PhD. · +84 77728736 · syacoub@oucru.org
Clinical Trials Unit Oxford University Clinical Research Unit · +84 28 3924 1983 · CTU-Ethics@oucru.org
Always discuss trial participation with your own doctor first.
| Universiti Malaya Medical Centre | Kuala Lumpur, Malaysia | Not Yet Recruiting |
| Hospital for Tropical Diseases, Ho Chi Minh city | Ho Chi Minh City, Vietnam | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06551844